Another study demonstrates that depletion of METTL3 or METTL14 could increase the sensitivity of anti-PD-1 therapy by supporting the function of cytotoxic tumor‐infiltrating CD8 T cells (Wang et al., 2020e). This evidence concerns the gene METTL3 and neoplasm.